TLR9 Immunotherapy for Peritoneal Carcinomatosis
TLR9 Immunotherapy for Peritoneal Carcinomatosis
Recruiting · NCT07658196 · Registry updated 2026-10-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TLR9 Immunotherapy for Peritoneal Carcinomatosis | Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Peritoneal Diseases, adenocarcinoma, appendix adenocarcinoma, carcinoma, colorectal adenocarcinoma, cystic, mucinous, and serous neoplasm, epithelial neoplasm, mucinous adenocarcinoma, neoplasm, peritoneal neoplasm | Recruiting | Phase 1 | 2026-10-01 | NCT07658196 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Brown University | 104 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Rhode Island and the Miriam Hospitals (Brown University Health) | Providence | United States | 3 |